1. Home
  2. OFG vs NTLA Comparison

OFG vs NTLA Comparison

Compare OFG & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OFG
  • NTLA
  • Stock Information
  • Founded
  • OFG 1964
  • NTLA 2014
  • Country
  • OFG United States
  • NTLA United States
  • Employees
  • OFG N/A
  • NTLA N/A
  • Industry
  • OFG Major Banks
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • OFG Finance
  • NTLA Health Care
  • Exchange
  • OFG Nasdaq
  • NTLA Nasdaq
  • Market Cap
  • OFG 2.0B
  • NTLA 1.4B
  • IPO Year
  • OFG N/A
  • NTLA 2016
  • Fundamental
  • Price
  • OFG $41.61
  • NTLA $12.22
  • Analyst Decision
  • OFG Buy
  • NTLA Buy
  • Analyst Count
  • OFG 3
  • NTLA 17
  • Target Price
  • OFG $49.67
  • NTLA $56.63
  • AVG Volume (30 Days)
  • OFG 328.2K
  • NTLA 2.3M
  • Earning Date
  • OFG 01-22-2025
  • NTLA 02-20-2025
  • Dividend Yield
  • OFG 2.40%
  • NTLA N/A
  • EPS Growth
  • OFG 8.35
  • NTLA N/A
  • EPS
  • OFG 4.13
  • NTLA N/A
  • Revenue
  • OFG $639,464,000.00
  • NTLA $43,086,000.00
  • Revenue This Year
  • OFG N/A
  • NTLA $52.50
  • Revenue Next Year
  • OFG $1.02
  • NTLA $0.42
  • P/E Ratio
  • OFG $10.11
  • NTLA N/A
  • Revenue Growth
  • OFG 2.17
  • NTLA N/A
  • 52 Week Low
  • OFG $33.19
  • NTLA $11.34
  • 52 Week High
  • OFG $47.66
  • NTLA $34.87
  • Technical
  • Relative Strength Index (RSI)
  • OFG 38.58
  • NTLA 40.01
  • Support Level
  • OFG $42.46
  • NTLA $11.34
  • Resistance Level
  • OFG $43.55
  • NTLA $12.30
  • Average True Range (ATR)
  • OFG 1.18
  • NTLA 0.67
  • MACD
  • OFG -0.13
  • NTLA 0.01
  • Stochastic Oscillator
  • OFG 25.60
  • NTLA 32.47

About OFG OFG Bancorp

OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. It provides services in the region of Puerto Rico.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: